PLSEPulse Biosciences, Inc.

Nasdaq pulsebiosciences.com


$ 17.60 $ 0.35 (2.04 %)    

Monday, 09-Sep-2024 15:59:54 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 17.54
$ 18.39
$ 17.58 x 100
-- x --
$ 17.32 - $ 19.13
$ 3.78 - $ 22.69
223,617
na
1.08B
$ 0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-12-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-16-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-03-2019 03-31-2019 10-Q
23 03-14-2019 12-31-2018 10-K
24 11-01-2018 09-30-2018 10-Q
25 07-31-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 03-16-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-10-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-20-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-10-2016 06-30-2016 10-Q
34 06-27-2016 03-31-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pulse-biosciences-announces-treatment-of-patients-in-first-in-human-study-with-its-nano-pfa-cardiac-surgery-system

Company's proprietary system used in study for patients with atrial fibrillationCardiac Surgery System enrolled in the FDA&...

 russell-2000-index-notches-strongest-week-of-year-hits-31-month-highs-outlook-is-clouded-by-feds-concerns-over-labor-market-analyst-warns

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-...

 pulse-biosciences-announces-preliminary-results-for-its-rights-offering-expected-to-generate-60m-in-immediate-gross-proceeds-for-the-co

Based on a preliminary tabulation by Broadridge Corporate Issuer Solutions, Inc. (the "Subscription Agent"), as of the ...

 pulse-biosciences-announces-commencement-of-rights-offering-of-up-to-60m-of-units

Pulse Biosciences, Inc. (NASDAQ:PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel an...

 pulse-biosciences-cellfx-nanosecond-pulsed-field-ablation-technology-will-be-featured-in-several-presentations-at-the-hrs-2024-annual-meeting

Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™...

 pulse-biosciences-appoints-burke-t-barrett-as-president-and-chief-executive-officer-former-president-and-ceo-kevin-danahy-appointed-as-chief-commercial-officer

Appoints proven atrial fibrillation medical technology leader Burke T. Barrett as President and Chief Executive OfficerFormer P...

 why-nuvve-holding-shares-are-trading-lower-by-around-30-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expect...

 oxford-industries-pvh-and-3-stocks-to-watch-heading-into-monday

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as fol...

 pulse-biosciences-q4-eps-022-up-from-025-yoy

Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION